These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
159 related articles for article (PubMed ID: 18430802)
21. Aliskiren: a novel renin inhibitor for hypertension. Tayal V; Kalra BS Indian Heart J; 2008; 60(1):69-72. PubMed ID: 19212031 [TBL] [Abstract][Full Text] [Related]
22. Angiotensin II suppression in humans by the orally active renin inhibitor aliskiren (SPP100). Comparison with enalapril. Hollenberg NK Curr Hypertens Rep; 2002 Aug; 4(4):269-70. PubMed ID: 12168611 [No Abstract] [Full Text] [Related]
23. ARBs or ACEIs, that is the question. Ishigami T; Uchino K; Umemura S Hypertens Res; 2006 Nov; 29(11):837-8. PubMed ID: 17345782 [No Abstract] [Full Text] [Related]
24. Moving beyond angiotensin II to also target aldosterone? Little WC; Kirkman PM J Am Coll Cardiol; 2009 Aug; 54(6):513-4. PubMed ID: 19643311 [No Abstract] [Full Text] [Related]
25. Renal and hormonal responses to direct renin inhibition with aliskiren in healthy humans. Fisher ND; Jan Danser AH; Nussberger J; Dole WP; Hollenberg NK Circulation; 2008 Jun; 117(25):3199-205. PubMed ID: 18559696 [TBL] [Abstract][Full Text] [Related]
26. Blockade of renin-angiotensin-aldosterone system in kidney and heart disease: how much do we need? Lim S Acta Med Indones; 2008 Jan; 40(1):34-7. PubMed ID: 19054878 [TBL] [Abstract][Full Text] [Related]
27. Pharmacokinetic/pharmacodynamic modeling of renin biomarkers in subjects treated with the renin inhibitor aliskiren. Hong Y; Dingemanse J; Mager DE Clin Pharmacol Ther; 2008 Jul; 84(1):136-43. PubMed ID: 18288088 [TBL] [Abstract][Full Text] [Related]
28. Anti-angiotensin therapy: new perspectives. Ramasubbu K; Mann DL; Deswal A Cardiol Clin; 2007 Nov; 25(4):573-80; vi-vii. PubMed ID: 18063161 [TBL] [Abstract][Full Text] [Related]
30. Angiotensinogen Exerts Effects Independent of Angiotensin II. Lu H; Wu C; Howatt DA; Balakrishnan A; Moorleghen JJ; Chen X; Zhao M; Graham MJ; Mullick AE; Crooke RM; Feldman DL; Cassis LA; Vander Kooi CW; Daugherty A Arterioscler Thromb Vasc Biol; 2016 Feb; 36(2):256-65. PubMed ID: 26681751 [TBL] [Abstract][Full Text] [Related]
31. Do we need yet another blocker of the renin-angiotensin system? Messerli FH; Re RN J Am Coll Cardiol; 2007 Mar; 49(11):1164-5. PubMed ID: 17367659 [No Abstract] [Full Text] [Related]
32. Inhibiting the renin-angiotensin system: why and in which patients. Berra K; Miller NH J Am Acad Nurse Pract; 2009 Jan; 21(1):66-75. PubMed ID: 19125897 [TBL] [Abstract][Full Text] [Related]
35. Vitamin D receptor signaling inhibits atherosclerosis in mice. Szeto FL; Reardon CA; Yoon D; Wang Y; Wong KE; Chen Y; Kong J; Liu SQ; Thadhani R; Getz GS; Li YC Mol Endocrinol; 2012 Jul; 26(7):1091-101. PubMed ID: 22638071 [TBL] [Abstract][Full Text] [Related]
36. The hazards of dual renin-angiotensin blockade in chronic kidney disease. Ku E; Park J; Vidhun J; Campese V Arch Intern Med; 2009 Jun; 169(11):1015-8. PubMed ID: 19506167 [No Abstract] [Full Text] [Related]
37. Maximizing inhibition of the renin-angiotensin system with high doses of converting enzyme inhibitors or angiotensin receptor blockers. Berl T Nephrol Dial Transplant; 2008 Aug; 23(8):2443-7. PubMed ID: 18467376 [No Abstract] [Full Text] [Related]
38. The role of the renin-angiotensin-aldosterone system in cardiovascular progenitor cell function. Qian C; Schoemaker RG; van Gilst WH; Roks AJ Clin Sci (Lond); 2009 Feb; 116(4):301-14. PubMed ID: 19138171 [TBL] [Abstract][Full Text] [Related]
39. Role of renin angiotensin system in angiogenesis: it is still elusive. Ichiki T Arterioscler Thromb Vasc Biol; 2004 Apr; 24(4):622-4. PubMed ID: 15059811 [No Abstract] [Full Text] [Related]